Cargando…
The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review
As women age, there is an overall decrease in androgen production due to decline of ovarian and adrenal function during menopause. Androgens have been demonstrated to play an important role in sexual motivation in women. As a result, many postmenopausal women experience Female Sexual Dysfunction (FS...
Autores principales: | Uloko, Maria, Rahman, Farah, Puri, Leah Ibrahim, Rubin, Rachel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674516/ https://www.ncbi.nlm.nih.gov/pubmed/36198811 http://dx.doi.org/10.1038/s41443-022-00613-0 |
Ejemplares similares
-
Evaluation and Management of Hypoactive Sexual Desire Disorder
por: Clayton, Anita H., et al.
Publicado: (2018) -
Management of hypoactive sexual desire disorder in women: current and emerging therapies
por: Nappi, Rossella E, et al.
Publicado: (2010) -
Flibanserin for Treating Hypoactive Sexual Desire Disorder
por: Sang, Jae Hong, et al.
Publicado: (2016) -
Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder
por: Revicki, Dennis A., et al.
Publicado: (2020) -
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
por: Parish, Sharon J., et al.
Publicado: (2021)